A detailed history of Rhumbline Advisers transactions in Veru Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 138,645 shares of VERU stock, worth $80,414. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,645
Previous 113,632 22.01%
Holding current value
$80,414
Previous $95,000 11.58%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.77 - $1.04 $19,260 - $26,013
25,013 Added 22.01%
138,645 $106,000
Q2 2024

Aug 01, 2024

BUY
$0.76 - $1.79 $84,251 - $198,434
110,857 Added 3994.85%
113,632 $95,000
Q3 2023

Nov 09, 2023

SELL
$0.72 - $1.33 $4,574 - $8,449
-6,353 Reduced 69.6%
2,775 $1,000
Q2 2023

Aug 08, 2023

SELL
$0.98 - $1.49 $84,876 - $129,047
-86,609 Reduced 90.47%
9,128 $10,000
Q1 2023

May 11, 2023

BUY
$1.16 - $6.41 $4,036 - $22,306
3,480 Added 3.77%
95,737 $111,000
Q4 2022

Feb 14, 2023

BUY
$4.78 - $15.01 $36,237 - $113,790
7,581 Added 8.95%
92,257 $487,000
Q3 2022

Nov 10, 2022

BUY
$10.22 - $23.7 $70,620 - $163,767
6,910 Added 8.89%
84,676 $975,000
Q2 2022

Aug 11, 2022

BUY
$4.35 - $15.85 $39,637 - $144,425
9,112 Added 13.27%
77,766 $879,000
Q1 2022

May 12, 2022

BUY
$4.55 - $6.41 $10,965 - $15,448
2,410 Added 3.64%
68,654 $332,000
Q4 2021

Feb 10, 2022

SELL
$5.89 - $9.73 $6,537 - $10,800
-1,110 Reduced 1.65%
66,244 $390,000
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $18,326 - $26,732
2,703 Added 4.18%
67,354 $575,000
Q2 2021

Aug 05, 2021

BUY
$7.24 - $11.2 $108,723 - $168,190
15,017 Added 30.26%
64,651 $522,000
Q1 2021

May 06, 2021

BUY
$8.05 - $20.78 $18,732 - $48,355
2,327 Added 4.92%
49,634 $535,000
Q4 2020

Feb 10, 2021

BUY
$2.36 - $9.99 $37,856 - $160,249
16,041 Added 51.3%
47,307 $409,000
Q3 2020

Nov 12, 2020

SELL
$2.58 - $3.36 $21,762 - $28,341
-8,435 Reduced 21.25%
31,266 $82,000
Q2 2020

Aug 13, 2020

BUY
$3.01 - $4.02 $119,500 - $159,598
39,701 New
39,701 $133,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.